Figure 1.

Proportion of patients with a decrease in T2 lesion volume or T1 black hole (BH) volume from baseline to Year 3, by interferon (IFN) β-1a dose group. sc, subcutaneously; tiw, three times weekly.

Bastianello et al. BMC Neurology 2011 11:125   doi:10.1186/1471-2377-11-125
Download authors' original image